[1] LÓPEZ-OTÍN C, BLASCO M A, PARTRIDGE L, et al. The hallmarks of aging[J]. Cell, 2013, 153(6):1194-1217. [2] BURTON D G, KRIZHANOVSKY V. Physiological and pathological consequences of cellular senescence[J]. Cell Mol Life Sci, 2014, 71(22):4373-4386. [3] RIESSLAND M.Cellular senescence in health, disease and aging: blessing or curse? [J]. Life:Basel, 2021, 11(6):541. [4] MUÑOZ-ESPÍN D, SERRANO M. Cellular senescence: from physiology to pathology[J]. Nat Rev Mol Cell Biol, 2014, 15(7):482-496. [5] ESPOSITO P, VERZOLA D, PICCIOTTO D, et al. Myostatin/activin-A signaling in the vessel wall and vascular calcification[J]. Cells, 2021, 10(8):2070. [6] BLUMENSATT M, GREULICH S, HERZFELD D E, et al. Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143[J]. Cardiovasc Res, 2013, 100(2):201-210. [7] CHANG S C, HSU C Y, LIU L K, et al. The association between serum activin A levels and albuminuria among community-dwelling middle-aged and older adults in Taiwan[J]. Sci Rep, 2021, 11(1):20032. [8] ZHANG D, GAVA A L, VAN KRIEKEN R, et al. The caveolin-1 regulated protein follistatin protects against diabetic kidney disease[J]. Kidney Int, 2019, 96(5):1134-1149. [9] 余红, 张川, 乐涛, 等. 血清CysC、MCP-1、ACT-A水平在评估老年COPD合并呼衰预后的价值分析[J]. 标记免疫分析与临床, 2022, 29(4):599-603. [10] 万清平. 血清sST2、UA、ACT-A水平变化与年龄>60岁急性心衰患者MACE风险的关系[J]. 罕少疾病杂志, 2022, 29(11):34-36. [11] 李鸿渐, 王思月. 血清sST2、ACT-A及NT-proBNP在慢性心力衰竭病人病情发生及发展中的临床意义[J]. 蚌埠医学院学报, 2022, 47(11):1509-1512, 1517. [12] LI Y, TENG D, SHI X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: nationalcross sectional study[J]. BMJ, 2020, 369:m997. [13] 董辉, 黄志红, 杨煜, 等. 不同年龄段健康成年人外周血激活素A水平的变化[J]. 中国老年学杂志, 2004,24(12):1131-1132. [14] AGUAYO-MAZZUCATO C, ANDLE J, LEE TB J R, et al. Acceleration of β cell aging determines diabetes and senolysis improves disease outcomes[J]. Cell Metab, 2019, 30(1):129-142.e4. [15] BIAN X, GRIFFIN T P, ZHU X, et al. Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy[J]. BMJ Open Diabetes Res Care, 2019, 7(1):e000720. [16] PAVLOU D I, PASCHOU S A, ANAGNOSTIS P, et al. Hypertension in patients with type 2 diabetes mellitus: targets and management[J].Maturitas, 2018, 112:71-77. [17] 赵雅洁, 沈琳辉, 王巍, 等. 脉压、脉压指数及估算估算肾小球滤过率在高血压患者中的应用[J]. 上海交通大学学报(医学版), 2007, 27(10):1258-1260. |